Forest Laboratories Inc, which is facing patent expirations on several of its biggest drugs, on Monday said it plans to buy rights to a new schizophrenia treatment from Merck & Co and cut annual operating costs by $500 million in fiscal 2016.
Healthcare Health/Fitness
Gerresheimer drops out of bidding for Rexam's healthcare packaging business
German medical supplies manufacturer Gerresheimer on Wednesday confirmed that it is no longer vying for UK-based Rexam's healthcare packaging unit. The company said the healthcare business did not fulfill its acquisition requirements.
Boehringer subsidiary hires Bank of America to explore sale of injectable drugs business
Ben Venue Laboratories, a subsidiary of German Boehringer Ingelheim in the US, has engaged Bank of American Merill Lynch to advise it on a proposed sale of its sterile injectable drugs business.
Top deals of the day - bids, mergers and acquisitions
The following bids, mergers, acquisitions and disposals were reported on tuesday including Adcock Ingram, Energa, Nordea Bank, Alitalia, Ben Venue, TIM Participacoes, Douglas, Mercator, Novartis, OncoMed, Kerning and Malaysia Airports
Salix Pharmaceuticals said to give rate proposal on Santarus acquisition loan
Bloomberg report said Salix Pharmaceuticals has proposed a rate for the USD 1.2 billion financing it will be getting for the purchase of Santarus Inc.
Latest News
Joint venture partners Accel Partners and Ventureast will own more than 30% stake in Portea Medical Group after equally investing INR48 crore in the in-home health services company.
South Africa's industrial conglomerate has joined forces with unlisted drug firm Community Investment Holdings (CIH) to buy a stake in Adcock Ingram in a move that could derail Chilean company CFR Pharmaceutical's takeover bid, said a Business Day Live report.
Servelec's initial public offering is said to be the largest technology listing in the UK in three years. The software and services company is expected to float 68.3 million shares worth GBP122 million on the London Stock Exchange.
Australia-based diagnostic device firm Sun Biomedical had been negotiating the acquisition of biodegradable heart surgery device Parvulus Medical in an exclusive arrangement that will conclude on January 15.
The Obama administration declared victory on Sunday in its effort to get HealthCare.gov working smoothly for the vast majority of users, saying the site had reached a goal of handling 50,000 simultaneous users after a five-week "tech surge."
Atrium Innovations Inc said a group of investors, including European private equity firm Permira funds, would buy the dietary supplements maker for about C$751.2 million.
Sydney-based medical services provider Primary Health Care is cutting down loan interest costs on a AUD 1.25 billion refinancing agreement, according to sources interviewed by Bloomberg.
Chuck Reed, the Mayor of San Jose, California, is leading a statewide voter initiative that aims to reduce skyrocketing costs of pension plans and retiree healthcare.
Chile-based drug firm CFR Pharmaceuticals promised a 25.1% stake for its black shareholders should the acquisition of local pharmaceutical company Adcock Ingram be approved, in line with South Africa's black economic empowerment (BEE) codes.
